Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Cellular Polyamines Promote Amyloid-Beta (A beta) Peptide Fibrillation and Modulate the Aggregation Pathways
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4530974
Author(s) Luo, Jinghui; Yu, Chien-Hung; Yu, Huixin; Borstnar, Rok; Kamerlin, Shina C. L.; Gräslund, Astrid; Abrahams, Jan Pieter; Wärmländer, Sebastian K. T. S.
Author(s) at UniBasel Abrahams, Jan Pieter
Year 2013
Title Cellular Polyamines Promote Amyloid-Beta (A beta) Peptide Fibrillation and Modulate the Aggregation Pathways
Journal ACS Chemical Neuroscience
Volume 4
Number 3
Pages / Article-Number 454-462
Keywords Alzheimer's disease; amyloid-beta peptide; natural polyamines; protein-ligand binding; protein aggregation-pathway; peptide fibrillation
Mesh terms Science & TechnologyLife Sciences & BiomedicineBiochemistry & Molecular BiologyChemistry, MedicinalNeurosciencesBiochemistry & Molecular BiologyPharmacology & PharmacyNeurosciences & Neurology
Abstract The cellular polyamines spermine, spermidine, and their metabolic precursor putrescine, have long been associated with cell-growth, tumor-related gene regulations, and Alzheimer's disease. Here, we show by in vitro spectroscopy and AFM imaging, that these molecules promote aggregation of amyloid-beta (A beta) peptides into fibrils and modulate the aggregation pathways. NMR measurements showed that the three polyamines share a similar binding mode to monomeric A beta(1-40) peptide. Kinetic ThT studies showed that already very low polyamine concentrations promote amyloid formation: addition of 10 mu M spermine (normal intracellular concentration is similar to 1 mM) significantly decreased the lag and transition times of the aggregation process. Spermidine and putrescine additions yielded similar but weaker effects. CD measurements demonstrated that the three polyamines induce different aggregation pathways, involving different forms of induced secondary structure. This is supported by AFM images showing that the three polyamines induce A beta(1-40) aggregates with different morphologies. The results reinforce the notion that designing suitable ligands which modulate the aggregation of A beta peptides toward minimally toxic pathways may be a possible therapeutic strategy for Alzheimer's disease.
Publisher American Chemical Society
ISSN/ISBN 1948-7193
edoc-URL https://edoc.unibas.ch/75916/
Full Text on edoc No
Digital Object Identifier DOI 10.1021/cn300170x
ISI-Number 000316594100011
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.347 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/04/2024